Monoclonal Antibody Infusion

Monoclonal Antibody Infusion is a therapy granted by the FDA’s Emergency Use Authorization (EUA) as a treatment for severe COVID-19 symptoms in patients at high risk of hospitalization.

Monoclonal Antibody Infusion is available now for patients who meet the following requirements:

  1. You have a positive COVID-19 test result
  2. You are not already hospitalized
  3. You have mild-to-moderate symptoms that started less than 10 days ago
  4. You have certain medical conditions or other health factors that place you at a higher risk of progressing to a severe infection:
    • Age 65 years or older
    • Obese or over weight which may include a Body Mass Index (BMI) of 25 or higher for adults or a BMI in the 85th percentile or higher on the growth chart for pediatric patients.
    • Pregnant
    • Diabetes
    • Chronic kidney disease
    • Immunosuppressive disease, or on immunosuppressive treatment
    • Cardiovascular disease (including congenital heart disease) or hypertension
    • Chronic lung disease such as chronic obstructive pulmonary disease (COPD), moderate to severe asthma, cystic fibrosis, or pulmonary hypertension)
    • Sickle cell disease

Related Links

2 thoughts on “Monoclonal Antibody Infusion

  1. Pingback: My Site

Leave a Reply

Your email address will not be published. Required fields are marked *